B-cell lymphoma marking only with anti-epithelial membrane antigen

Area of Science:

• Immunology
• Biochemistry
• Cell Biology

Background:

• B-cell lymphomas can exhibit diverse surface markers.
• Epithelial membrane antigen (EMA) expression is typically associated with epithelial cells, but its presence on lymphoma requires further investigation.
• Understanding cell surface carbohydrates is crucial for characterizing malignancy and differentiation.

Purpose of the Study:

• To characterize the molecular nature of epithelial membrane antigen (EMA) expression on a specific B-cell lymphoma.
• To identify the specific carbohydrate epitope responsible for EMA binding on the lymphoma cell surface.
• To investigate the potential implications of EMA expression for lymphoma cell differentiation.

Main Methods:

• Immunohistochemistry using anti-EMA antibody.
• Affinity absorption assays with specific carbohydrates (N-acetyl-galactosamine, N-acetylglucosamine, d-galactose).
• Lectin binding studies using soybean agglutinin and wheat germ agglutinin.
• Enzymatic digestion of lymphoma sections with N-acetylgalactosaminidase.

Main Results:

• The B-cell lymphoma showed strong plasma membrane marking with anti-EMA.
• N-acetyl-galactosamine specifically inhibited the antibody binding, indicating its involvement in the epitope.
• Soybean agglutinin, but not wheat germ agglutinin, bound to the lymphoma membrane, further supporting a galactosamine-related structure.
• Enzymatic removal of N-acetylgalactosamine abolished EMA marking, confirming it as the key component.

Conclusions:

• The B-cell lymphoma expresses a membrane-bound complex carbohydrate dominated by galactosamine.
• This finding suggests a potential link between EMA expression and a late differentiation stage, possibly resembling plasma cells.